Related Experiment Video
Updated: May 10, 2026

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using Poly(I:C) to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
Prenatal maternal antibiotic use increases the risk of childhood eczema: a systematic review and meta-analysis
Szilárd Petrás1, Bettina Vargáné Szabó1, Tivadar Kiss2
1Institute of Clinical Pharmacy, Faculty of Pharmacy, University of Szeged, Szikra u. 6. Szeged, H-6725, Szeged, Hungary.
Insights
Maternal antibiotic use during pregnancy, particularly before birth, is linked to an increased risk of childhood atopic dermatitis. This finding suggests careful consideration of antibiotic prescriptions during pregnancy for infant health.
Area of Science:
- Microbiome research
- Developmental pediatrics
- Pharmacology
Background:
- Early-life microbiome disruption negatively impacts health.
- The long-term effects of maternal medication use on the gut microbiota and offspring health are not fully understood.
Purpose of the Study:
- To assess the association between maternal antibiotic use during pregnancy (prenatal or intrapartum) and the risk of childhood atopic dermatitis.
- To synthesize evidence from existing cohort and case-control studies.
Main Methods:
- A comprehensive meta-analysis was performed using data from EMBASE, PubMed, Cochrane, and Web of Science.
- Included 30 studies encompassing over 4.1 million mothers and 4.3 million children.
- Analyzed data using random effects models and adjusted for publication bias with the trim-and-fill method.
Main Results:
- Prenatal antibiotic exposure was significantly associated with a higher risk of childhood atopic dermatitis (adjusted odds ratio: 1.32).
- This association remained significant after adjusting for publication bias (adjusted odds ratio: 1.22).
- Intrapartum antibiotic use did not show a significant association with increased risk of childhood atopic dermatitis (odds ratio: 1.64).
Conclusions:
- Prenatal antibiotic use during pregnancy may have a modest but significant impact on the risk of developing atopic dermatitis in offspring.
- Findings underscore the importance of evaluating antibiotic prescribing practices during pregnancy concerning long-term child health outcomes.
- Further research may be warranted to explore mechanisms and clinical implications.
Abstract:
Early-life disruption of microbiome development is known to impair health; however, the long-term effects of pregnancy-related pharmacological alterations to the maternal gut microbiota on offspring health remain unclear. This meta-analysis aimed to evaluate the impact of maternal antibiotic use (either prenatal or intrapartum) on the risk of childhood atopic dermatitis, based on cohort and case-control studies. Literature searches were conducted in EMBASE, PubMed, Cochrane, and Web of Science databases using predefined PICO (patients, intervention, comparison, outcome) criteria. Overall, our meta-analysis included 30 studies with a total of 4,125,143 mothers and 4,346,050 children. Using the random effects model, our study found that prenatal antibiotic use was associated with higher odds of atopic dermatitis in childhood (aOR: 1.32; 95% CI: 1.12; 1.56). This result remained significant after adjusting publication bias by the trim-and-fill method (aOR: 1.22; 95% CI: 1.03; 1.44), highlighting the potential relevance of antibiotic prescribing practices during pregnancy in relation to childhood atopic disease risk. Intrapartum antibiotic use was not associated with elevated risk for atopic dermatitis in the children (OR: 1.64; 95% CI: 0.84; 3.17). Prenatal antibiotic use appears to have a modest effect on atopic dermatitis in offspring.
More Related Videos
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Related Concept Videos
Development of the Oral Microbiota
Development of Human Microbiota
Acne Infection
Asthma I: Introduction
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Clinical Significance of Antibiotic Resistance